Evaluation of persistence, retention “rate” and prescription pattern of original infliximab and infliximab CT-P13 in biologic-naïve patients with ulcerative colitis

To compare the persistence, retention rate and prescription pattern of original infliximab and infliximab CT-P13 in biologic-naive patients with ulcerative colitis. This was an ambispective study of biologic-naive patients with ulcerative colitis who received non-simultaneous first-line treatment wi...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Farmacia hospitalaria 2022-09, Vol.46 (5), p.296-300
Hauptverfasser:	Valcuende-Rosique, Alejandro, Borrás-Blasco, Joaquín, Martínez-Badal, Sandra, Cortes, Xavier, Aparicio-Rubio, Celia, Casterá-Melchor, Elvira
Format:	Artikel
Sprache:	eng ; spa
Schlagworte:	Antibodies, Monoclonal Biosimilar Pharmaceuticals Colitis ulcerosa Colitis, Ulcerative - drug therapy Fármaco biosimilar Humans Infliximab Infliximab - therapeutic use Infliximab CT-P13 Persistence Persistencia Prescriptions Retention rate Tasa de retención Treatment Outcome Ulcerative colitis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!